Figure 5 indicates that cerebrovascular disease, an APACHE II score of 19, abnormal lactate and hemoglobin levels, CRP, and dexmedetomidine use raised the patient's risk for new-onset functional impairment, while a CCI of 2, normal blood pH, no fracture diagnosis, and no MV use mitigated this risk. This evidence concerns the gene CRP and cerebrovascular disorder.